ribavirin has been researched along with Chickungunya Fever in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (88.89) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Keller, PA; Mahalingam, S; Rashad, AA | 1 |
| Bhakat, S; Jayaprakash, V; Karubiu, W; Soliman, ME | 1 |
| Chai, CL; Ching, KC; Kam, YW; Merits, A; Ng, LF | 1 |
| Amrun, SN; Chai, CL; Ching, KC; Kam, YW; Ng, LF; Tran, TN | 1 |
| Aquino, TM; Araújo-Júnior, JX; da Silva-Júnior, EF; Leoncini, GO; Rodrigues, ÉES | 1 |
| Fernando, D; Herath, T; Rajapakse, S; Rodrigo, C; Wickramarachchi, U | 1 |
| Bahrani, H; Mohamed, Z; Rahman, NA; Rothan, HA; Shankar, EM; Teoh, TC; Yusof, R | 1 |
| Abdulrahman, AY; Bahrani, H; Mohamed, Z; Othman, S; Rahman, NA; Rashid, NN; Rothan, HA; Teoh, TC; Yusof, R | 1 |
| Burt, FJ; Heise, MT; Mahalingam, S; Rolph, MS; Rulli, NE | 1 |
4 review(s) available for ribavirin and Chickungunya Fever
| Article | Year |
|---|---|
A perspective on targeting non-structural proteins to combat neglected tropical diseases: Dengue, West Nile and Chikungunya viruses.
Topics: Antiviral Agents; Chikungunya Fever; Chikungunya virus; Dengue; Dengue Virus; Protein Conformation; Viral Nonstructural Proteins; Viral Vaccines; West Nile Fever; West Nile virus | 2014 |
The medicinal chemistry of Chikungunya virus.
Topics: Animals; Antiviral Agents; Biological Products; Chemistry, Pharmaceutical; Chikungunya Fever; Chikungunya virus; Dose-Response Relationship, Drug; Humans; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship | 2017 |
Treatment of chikungunya-associated joint pain: a systematic review of controlled clinical trials.
Topics: Anti-Inflammatory Agents; Arthralgia; Chikungunya Fever; Chloroquine; Humans; Hydroxychloroquine; Methotrexate; Observational Studies as Topic; Retrospective Studies; Ribavirin | 2022 |
Chikungunya: a re-emerging virus.
Topics: Aedes; Africa; Alphavirus Infections; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Viral; Antiviral Agents; Arthralgia; Asia; Chikungunya Fever; Chikungunya virus; Chloroquine; Communicable Diseases, Emerging; Disease Outbreaks; Europe; Humans; Indian Ocean Islands; Insect Vectors; Ribavirin; Viral Vaccines | 2012 |
5 other study(ies) available for ribavirin and Chickungunya Fever
| Article | Year |
|---|---|
Chikungunya virus: emerging targets and new opportunities for medicinal chemistry.
Topics: Alphavirus Infections; Chikungunya Fever; Chikungunya virus; Disease Outbreaks; Europe; Humans; Models, Molecular | 2014 |
Trisubstituted Thieno[3,2-b]pyrrole 5-Carboxamides as Potent Inhibitors of Alphaviruses.
Topics: Antiviral Agents; Chikungunya Fever; Chikungunya virus; HEK293 Cells; Humans; Nucleic Acid Synthesis Inhibitors; Protein Biosynthesis; Pyrroles; RNA, Viral; Structure-Activity Relationship; Viral Proteins | 2015 |
Structural Optimizations of Thieno[3,2-b]pyrrole Derivatives for the Development of Metabolically Stable Inhibitors of Chikungunya Virus.
Topics: Animals; Antiviral Agents; Chikungunya Fever; Chikungunya virus; Drug Design; HEK293 Cells; Humans; Mice, Inbred C57BL; Microsomes, Liver; Pyrroles; RNA, Viral | 2017 |
A combination of doxycycline and ribavirin alleviated chikungunya infection.
Topics: Animals; Antiviral Agents; Chikungunya Fever; Chikungunya virus; Chlorocebus aethiops; Doxycycline; Drug Evaluation, Preclinical; Drug Therapy, Combination; Mice, Inbred ICR; Ribavirin; Vero Cells; Virus Attachment; Virus Replication | 2015 |
Mefenamic acid in combination with ribavirin shows significant effects in reducing chikungunya virus infection in vitro and in vivo.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antiviral Agents; Cell Line; Chikungunya Fever; Chikungunya virus; Chlorocebus aethiops; Drug Therapy, Combination; Humans; Kidney; Liver; Meclofenamic Acid; Mefenamic Acid; Mice; Mice, Inbred ICR; Ribavirin; Spleen; Vero Cells; Viral Load; Virus Attachment; Virus Inactivation; Virus Internalization; Virus Replication | 2016 |